Copper and SAHH
I’m still digging Methylation topic.
This time a piece in Richard Deth’s book (“Molecular Origins of Human Attention”) about SAHH and copper got my attention and I went to read the references.
I want to share a few highlights:
-
SAHH is copper-binding enzyme and copper availability regulates abundance of the enzyme: “Copper deficiency led to decreased levels of SAHH in the liver cytosols from both moderately and severely copper-deficient mice. A ≈45% decrease in SAHH levels was detected in both moderately and severely deficient mice” (R1)
-
“the liver contains ≈12 times more SAHH than the kidney, which in turn contains ≈5 times more SAHH than the brain.” (R1).
-
SAHH activity is regulated by the ratio NAD/NADH and adenosine level. NADH inhibits activity and must be removed and replaced with NAD to restore activity. So whichever cycle controls NAD/NADH ratio will be responsible for Methylation potential too. (R2)
-
But divalent Copper seems to inhibit SAHH activity by releasing the NAD cofactor from the enzyme (R3):
The experimental results showed that Cu2+ inhibited SAHH activity in a noncompetitive manner. Binding of Cu2+ to SAHH resulted in the release of NAD+ cofactors, explaining the loss of the enzymatic activity of SAHH.
However, Cu2+ is not the active form of copper that is found inside the cell - it’s Cu1+ that is imported into the cell and distributed using GSH and chaperone proteins to the target enzymes.
My summary
-
Seems like copper deficiency should be avoided to ensure sufficient level of SAHH enzyme.
-
NAD to NADH ratio is critical. That is, timely NADH removal should be ensured.
-
Adenosine and homocysteine clearance is essential for SAHH to operate in the SAH-reducing direction.